Subtle Medical

Subtle Medical is a private, commercial-stage company founded in 2017 as a Stanford spin-out, specializing in AI-powered medical imaging enhancement. It has secured 9 FDA clearances for its software suite, which includes SubtleMR™, SubtlePET™, and the integrated Subtle-ELITE™ package for MRI. With over $50M raised and software deployed on nearly a thousand scanners globally, the company aims to improve radiology workflow efficiency, patient throughput, and safety by reducing scan times and contrast agent dosage. Its leadership combines deep technical AI expertise with clinical radiology experience.

Proprietary deep learning platform for medical image acquisition and reconstruction, enabling denoising, sharpening, synthetic contrast generation, and scan time acceleration for MRI and PET. Vendor-neutral software integrates with existing scanner hardware.

Operates in the crowded AI medical imaging market, competing with pure-play AI companies like Arterys, Aidoc, and Zebra Medical, as well as internal development teams at major scanner manufacturers (GE, Siemens, Philips). Differentiation is based on a focus on the acquisition phase, a vendor-neutral approach, and a suite of FDA-cleared products for both MRI and PET acceleration.